Literature DB >> 15350176

Breast arterial calcifications as a cardiovascular risk marker in women.

Pavel Crystal1, Julian Zelingher, Eugene Crystal.   

Abstract

Cardiovascular disease and breast cancer are the two main causes of mortality in women. Mammography as a screening test for breast cancer is recommended for all women from the age of 40 to 50 years. Mammographically detected breast arterial calcifications are currently considered an incidental finding without clinical importance, since they are not associated with an increased risk of breast cancer. However, recent studies have shown that breast arterial calcifications on mammograms have been associated with cardiovascular risk factors and atherosclerotic cardiovascular disease. These results suggest that breast arterial calcifications, detected during routine mammography, are a noteworthy finding that could be valuable in identifying asymptomatic women at increased cardiovascular risk.

Entities:  

Mesh:

Year:  2004        PMID: 15350176     DOI: 10.1586/14779072.2.5.753

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

1.  Mammograms and breast arterial calcifications: looking beyond breast cancer: a preliminary report.

Authors:  Rachael A Akinola; Okeoghene A Ogbera; Josephine Aa Onakoya; Chris E Enabulele; Idowu O Fadeyibi
Journal:  BMC Res Notes       Date:  2011-06-20

2.  Breast arterial calcifications as an indicator of atherosclerotic cardiovascular disease: comparative analysis of coronary computed tomography scoring systems and carotid intima-media thickness.

Authors:  Aykut Kadıoğlu; Suzan Bahadır
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  Microvascular Disease and Small-Vessel Disease: The Nexus of Multiple Diseases of Women.

Authors:  Hena Patel; Neelum T Aggarwal; Anupama Rao; Elizabeth Bryant; Rupa M Sanghani; Mary Byrnes; Dinesh Kalra; Leigh Dairaghi; Lynne Braun; Sherine Gabriel; Annabelle Santos Volgman
Journal:  J Womens Health (Larchmt)       Date:  2020-02-19       Impact factor: 2.681

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.